Developer docs
API playgroundTry for free, no card

Search company profiles

Laboratorios Syva

Full company profile

uuid000j74s

Namestring
Laboratorios Syva
Legal namestring
LABORATORIOS SYVA, S.A.
Websiteurl
syva.es
Company typeenum
Private
Founded yearint
1941
Descriptiontext

Laboratorios Syva is a privately held Spanish veterinary pharmaceutical company founded in 1941 and headquartered in León's Technology Park. It develops, registers, manufactures, and distributes vaccines and antibiotics — both immunologicals (viral and bacterial, live and inactivated) and betalactam anti-infectives — for livestock (bovine, porcine, ovine, caprine, poultry, equine) and companion animals (cats, dogs), with additional coverage of fish, deer, and other species. Its manufacturing footprint comprises three dedicated plants in Spain: the historical Planta Farmacoló gicos (since 1941), the Planta Inmunológicos (inaugurated 2008, covering over 12,000 m² with 13.5 million unit / 675 million vaccine dose annual capacity), and the Planta Betalactámicos (relocated in 2017 to the Technology Park).

The company's commercial model combines direct sales in Spain, three wholly owned subsidiaries in Portugal (IAPSA), Mexico (founded 1993), and Turkey (established 2020), and a network of exclusive and authorized distributors covering more than 60 countries organized into three regional areas. Revenue is generated primarily through sale of veterinary pharmaceuticals under prescription, supplemented by contract manufacturing services (CMO) for third parties in betalactams and immunologics. Differentiated offerings include ORBYK EHD — the first and only EU-authorized DIVA subunit vaccine against Epizootic Hemorrhagic Disease in cattle — and Syvazul BTV3 for Bluetongue serotype 3, both targeting vector-borne diseases. Syva also operates SyvaStart, an open R&D collaboration platform with universities and research centers (Universidad de León, CNB, VISAVET/UCM, Universidad de Santiago de Compostela, CIBIR, ANSES), and runs the long-standing Premio SYVA Internacional thesis award.

Syva is governed as a privately held corporation (LABORATORIOS SYVA, S.A.), with no identified parent entity, institutional investor, or public listing. Operations are led by CEO Cesar Carnicer, and the company maintains active memberships in the Spanish industry association Veterindustria and the European federation AnimalhealthEurope.

Short descriptiontext

Laboratorios Syva is a privately held Spanish veterinary pharmaceutical company, founded in 1941, that develops, manufactures, and distributes vaccines and antibiotics for livestock and companion animals across more than 60 countries via three wholly owned subsidiaries and a global distributor network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLeón, Spain
HQ citystring
León
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary pharmaceuticals, livestock vaccines, animal antibiotics, veterinary biologics, contract manufacturing
Industry1 code
PRIMARYHLAMAKAI
Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO)
SIC code1 code
  • Agricultural Prod-Livestock & Animal Specialties200
Product category
Veterinary Pharmaceuticals
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Veterinary Pharmaceuticals Sales
TypeOne Time License
Description

Sale of vaccines and antibiotics for livestock (bovine, porcine, ovine, caprine, poultry, fish, equine) and companion animals (cats, dogs). Products include vaccines for vector-borne diseases (EHE, Bluetongue) and anti-infectives including betalactams.

syva.es
2Contract Manufacturing (CMO)
TypeProfessional Services
Description

Syva offers contract manufacturing services for third parties with direct involvement in all stages of the process. They provide technical, regulatory, and scientific support during all phases for betalactams and immunologics manufacturing.

syva.es
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Laboratorios Syva is a Spanish veterinary pharmaceutical manufacturer that develops, registers, and commercializes vaccines (immunologics) and antibiotics (betalactams and other anti-infectives) for livestock (bovine, porcine, ovine, caprine, poultry, fish, equine) and companion animals (cats, dogs). The company also offers contract manufacturing services for third parties, leveraging three own manufacturing plants in Spain with capacity of 13.5 million units (675 million vaccine doses) annually.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Production capacity of 675 million vaccine doses annually at immunologics plant
+2 more records
Product overview1 text field

Laboratorios Syva is a veterinary pharmaceutical company specializing in animal health solutions, primarily offering vaccines (immunologicals) and antibiotics (betalactámicos and pharmacologicals) for livestock and companion animals. The company operates three manufacturing plants in Spain producing vaccines (covering 12,000 m² with capacity of 13.5 million units/675 million doses), beta-lactam antibiotics, and general pharmaceutical products. Syva's product portfolio spans multiple animal species (porcine, bovine, ovine, caprine, poultry, fish, equine, feline, canine, deer) and includes notable vaccines such as ORBYK EHD (EHE DIVA vaccine), Syvazul® BTV3 (Bluetongue vaccine), and Syvac® Ery Parvo. The company also offers contract manufacturing services (CMO) and operates internationally through subsidiaries in Portugal, Mexico, and Turkey, plus distribution networks in over 60 countries.

Product and service7 records
1ORBYK EHD (formerly Syvac EH Marker)
CategoryVaccine (Livestock/Bovine)
Description

First and only DIVA (Differentiating Infected from Vaccinated Animals) subunit vaccine providing differentiated protection against Epizootic Hemorrhagic Disease (EHD) caused by serotype 8 in cattle. The only European market vaccine enabling differentiation between infected and non-infected animals.

2Syvazul BTV3
CategoryVaccine (Livestock/Ovine & Bovine)
Description

Vaccine for Bluetongue serotype 3 (BTV3) providing protection against this vector-borne disease transmitted by Culicoides midges, authorized for use in sheep and cattle.

3Syvac Ery Parvo
CategoryVaccine (Livestock/Porcine)
Description

Vaccine for simultaneous control of Mal Rojo (Erysipelas) and Porcine Parvovirus (PPV) in pig herds, enabling individualized control protocols for each farm.

4Immunologicals and Vaccines Portfolio
CategoryVaccines / Immunologics
Description

Complete portfolio of vaccines (viruses, bacteria, live or inactivated) produced at the dedicated Immunologicals plant, covering multiple animal species for prevention of vector-borne and infectious diseases.

5Betalactam Antibiotics
CategoryAntibiotics / Betalactams
Description

Pharmaceutical specialties incorporating beta-lactam active principles (antibiotics) for veterinary use, manufactured at the dedicated plant in León's technology park.

6Pharmacological Products
CategoryPharmacologicals / Serums
Description

Farm medications and related pharmaceutical products, including serums and vaccines, produced at the historical Pharmacologicals plant since 1941.

7Contract Manufacturing (CMO) Services
CategoryManufacturing Services (CMO)
Description

Contract manufacturing services offering technical, regulatory, and scientific support during all phases of development, registration, and manufacturing of vaccines and antibiotics for third parties, leveraging three owned manufacturing sites in Spain.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeOthers
Description

Spanish Business Association of the Animal Health and Nutrition Industry. Founded 1977, works in defense of interests of Spanish companies dedicated to manufacturing and/or commercialization of veterinary medicines, animal health and nutrition products, and nutritional additives. Represents nearly all companies in the sector.

Strategic tierCoreTypeOthers
Description

Association representing manufacturers of animal medicines, vaccines, and other animal health products in Europe. Non-profit organization representing corporate members and national associations. Membership covers 90% of the European animal health products market.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partner for research collaborations. Co-organizer of Premio SYVA Internacional award and host of annual ceremony. Also hosts R&D laboratories at the university.

4Centro Nacional de Biotecnología (CNB)
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

National research center for biotechnology, part of the SyvaStart network for collaborations with academic institutions.

syva.es
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

University research center part of the SyvaStart network for collaborations in animal health research.

6Universidad de Santiago de Compostela
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Galician university partner in the SyvaStart network for animal health research collaborations.

syva.es
7CIBIR (Centro de Investigación Biomédica de La Rioja)
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Biomedical research center in La Rioja, part of the SyvaStart research network.

syva.es
8ANSES (Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail)
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

French food, environment and occupational health safety agency. Part of SyvaStart network for international research collaborations in animal health.

syva.es
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Spanish-headquartered veterinary pharmaceutical company specializing in vaccines and immunology for livestock and companion animals. Closest geographic and product peer to Syva, both based in Catalonia/León region with comparable species coverage and CMO capabilities for veterinary biologics.

TypeBroad incumbent
Description

World's largest animal health company offering vaccines, anti-infectives, parasiticides, and diagnostics across livestock and companion animals. Competes with Syva in core vaccine and antibiotic categories but at significantly larger scale and broader geographic footprint.

3Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Global animal health division of Boehringer Ingelheim and a top-three player in livestock vaccines, including strong positions in bovine and porcine biologicals. Directly competes with Syva in livestock vaccines and therapeutics across the EU and global markets.

TypeDirect peer
Description

French-headquartered global animal health company focused on vaccines, pharmaceuticals, and equipment for livestock and companion animals. Comparable to Syva in species breadth and vaccine-led portfolio, though at materially larger scale.

TypeDirect peer
Description

French-listed global animal health company offering vaccines, parasiticides, and pharmaceuticals for livestock and pets. Similar mid-sized independent positioning, multi-species portfolio, and CMHO/CDMO relevance to Syva, making it a key structural comparator.

TypeDirect peer
Description

Independent French-listed animal health company with a portfolio of pharmaceuticals and vaccines for livestock and companion animals. Comparable mid-sized European competitor with similar species and therapeutic-area coverage to Syva.

TypeBroad incumbent
Description

Large US-listed global animal health company offering livestock vaccines, antibiotics, parasiticides, and companion animal therapeutics. Overlaps with Syva in livestock pharmaceuticals and anti-infectives at a much larger scale.

TypeBroad incumbent
Description

Animal health division of Merck & Co., a global leader in livestock and companion animal vaccines and pharmaceuticals. Competes with Syva in vector-borne disease vaccines (Bluetongue, EHD) and in core livestock anti-infectives, with vastly deeper R&D resources.

TypeDirect peer
Description

US-listed animal health and nutrition company with significant livestock pharmaceutical and vaccine businesses, including a meaningful nutritional/health products portfolio. Mid-sized independent competitor with overlapping species focus and therapeutic categories.

TypeEmerging player
Description

India-based veterinary vaccine manufacturer with growing presence in livestock and aquaculture biologics in Asia, Africa, and Latin America. Earlier-stage and geographically focused, but operationally relevant as a low-cost veterinary vaccine producer competing in emerging markets where Syva also distributes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Laboratorios Syva

Veterinary Pharmaceuticalssyva.es

Laboratorios Syva is a privately held Spanish veterinary pharmaceutical company, founded in 1941, that develops, manufactures, and distributes vaccines and antibiotics for livestock and companion animals across more than 60 countries via three wholly owned subsidiaries and a global distributor network.

What Laboratorios Syva does

Laboratorios Syva is a privately held Spanish veterinary pharmaceutical company founded in 1941 and headquartered in León's Technology Park. It develops, registers, manufactures, and distributes vaccines and antibiotics — both immunologicals (viral and bacterial, live and inactivated) and betalactam anti-infectives — for livestock (bovine, porcine, ovine, caprine, poultry, equine) and companion animals (cats, dogs), with additional coverage of fish, deer, and other species. Its manufacturing footprint comprises three dedicated plants in Spain: the historical Planta Farmacoló gicos (since 1941), the Planta Inmunológicos (inaugurated 2008, covering over 12,000 m² with 13.5 million unit / 675 million vaccine dose annual capacity), and the Planta Betalactámicos (relocated in 2017 to the Technology Park).

The company's commercial model combines direct sales in Spain, three wholly owned subsidiaries in Portugal (IAPSA), Mexico (founded 1993), and Turkey (established 2020), and a network of exclusive and authorized distributors covering more than 60 countries organized into three regional areas. Revenue is generated primarily through sale of veterinary pharmaceuticals under prescription, supplemented by contract manufacturing services (CMO) for third parties in betalactams and immunologics. Differentiated offerings include ORBYK EHD — the first and only EU-authorized DIVA subunit vaccine against Epizootic Hemorrhagic Disease in cattle — and Syvazul BTV3 for Bluetongue serotype 3, both targeting vector-borne diseases. Syva also operates SyvaStart, an open R&D collaboration platform with universities and research centers (Universidad de León, CNB, VISAVET/UCM, Universidad de Santiago de Compostela, CIBIR, ANSES), and runs the long-standing Premio SYVA Internacional thesis award.

Syva is governed as a privately held corporation (LABORATORIOS SYVA, S.A.), with no identified parent entity, institutional investor, or public listing. Operations are led by CEO Cesar Carnicer, and the company maintains active memberships in the Spanish industry association Veterindustria and the European federation AnimalhealthEurope.

Laboratorios Syva firmographics

Firmographics
Name
Laboratorios Syva
Legal name
LABORATORIOS SYVA, S.A.
Website
https://syva.es
Company type
Private
Founded year
1941
Operating status
Operating
Headcount range
251–500 employees
Short description
Laboratorios Syva is a privately held Spanish veterinary pharmaceutical company, founded in 1941, that develops, manufactures, and distributes vaccines and antibiotics for livestock and companion animals across more than 60 countries via three wholly owned subsidiaries and a global distributor network.
Ownership category
akta.pro rank

Laboratorios Syva industry classification

Industry
Product category
Veterinary Pharmaceuticals
SIC
Agricultural Prod-Livestock & Animal Specialties (200)
akta.pro industry
PRIMARYHLAMAKAI
Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO)

Keywords

  • Veterinary pharmaceuticals
  • Livestock vaccines
  • Animal antibiotics
  • Veterinary biologics
  • Contract manufacturing

Where Laboratorios Syva is headquartered

Location

Headquarters

HQ city
León
HQ country
Spain
HQ region
Europe

Offices6 records

Markets served

Laboratorios Syva business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Veterinary Pharmaceuticals Sales: Sale of vaccines and antibiotics for livestock (bovine, porcine, ovine, caprine, poultry, fish, equine) and companion animals (cats, dogs). Products include vaccines for vector-borne diseases (EHE, Bluetongue) and anti-infectives including betalactams.
  2. Contract Manufacturing (CMO): Syva offers contract manufacturing services for third parties with direct involvement in all stages of the process. They provide technical, regulatory, and scientific support during all phases for betalactams and immunologics manufacturing.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Laboratorios Syva product offering

Product offering

Core offering

Laboratorios Syva is a Spanish veterinary pharmaceutical manufacturer that develops, registers, and commercializes vaccines (immunologics) and antibiotics (betalactams and other anti-infectives) for livestock (bovine, porcine, ovine, caprine, poultry, fish, equine) and companion animals (cats, dogs). The company also offers contract manufacturing services for third parties, leveraging three own manufacturing plants in Spain with capacity of 13.5 million units (675 million vaccine doses) annually.

Product overview

Laboratorios Syva is a veterinary pharmaceutical company specializing in animal health solutions, primarily offering vaccines (immunologicals) and antibiotics (betalactámicos and pharmacologicals) for livestock and companion animals. The company operates three manufacturing plants in Spain producing vaccines (covering 12,000 m² with capacity of 13.5 million units/675 million doses), beta-lactam antibiotics, and general pharmaceutical products. Syva's product portfolio spans multiple animal species (porcine, bovine, ovine, caprine, poultry, fish, equine, feline, canine, deer) and includes notable vaccines such as ORBYK EHD (EHE DIVA vaccine), Syvazul® BTV3 (Bluetongue vaccine), and Syvac® Ery Parvo. The company also offers contract manufacturing services (CMO) and operates internationally through subsidiaries in Portugal, Mexico, and Turkey, plus distribution networks in over 60 countries.

Differentiator

Problem solved

Functional benefit

Products and services

  • ORBYK EHD (formerly Syvac EH Marker) First and only DIVA (Differentiating Infected from Vaccinated Animals) subunit vaccine providing differentiated protection against Epizootic Hemorrhagic Disease (EHD) caused by serotype 8 in cattle. The only European market vaccine enabling differentiation between infected and non-infected animals.
  • Syvazul BTV3 Vaccine for Bluetongue serotype 3 (BTV3) providing protection against this vector-borne disease transmitted by Culicoides midges, authorized for use in sheep and cattle.
  • Syvac Ery Parvo Vaccine for simultaneous control of Mal Rojo (Erysipelas) and Porcine Parvovirus (PPV) in pig herds, enabling individualized control protocols for each farm.
  • Immunologicals and Vaccines Portfolio Complete portfolio of vaccines (viruses, bacteria, live or inactivated) produced at the dedicated Immunologicals plant, covering multiple animal species for prevention of vector-borne and infectious diseases.
  • Betalactam Antibiotics Pharmaceutical specialties incorporating beta-lactam active principles (antibiotics) for veterinary use, manufactured at the dedicated plant in León's technology park.
  • Pharmacological Products Farm medications and related pharmaceutical products, including serums and vaccines, produced at the historical Pharmacologicals plant since 1941.
  • Contract Manufacturing (CMO) Services Contract manufacturing services offering technical, regulatory, and scientific support during all phases of development, registration, and manufacturing of vaccines and antibiotics for third parties, leveraging three owned manufacturing sites in Spain.

Quantifiable outcome

  • Production capacity of 675 million vaccine doses annually at immunologics plant
  • +2 more outcomes

Companies that use Laboratorios Syva

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Laboratorios Syva technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Laboratorios Syva partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and secondary.

  • VeterindustriacoreOthersSpanish Business Association of the Animal Health and Nutrition Industry. Founded 1977, works in defense of interests of Spanish companies dedicated to manufacturing and/or commercialization of veterinary medicines, animal health and nutrition products, and nutritional additives. Represents nearly all companies in the sector.
  • AnimalhealthEuropecoreOthersAssociation representing manufacturers of animal medicines, vaccines, and other animal health products in Europe. Non-profit organization representing corporate members and national associations. Membership covers 90% of the European animal health products market.
  • Universidad de LeóncoreStrategic or Co-development PartnerAcademic partner for research collaborations. Co-organizer of Premio SYVA Internacional award and host of annual ceremony. Also hosts R&D laboratories at the university.
  • Centro Nacional de Biotecnología (CNB)secondaryStrategic or Co-development PartnerNational research center for biotechnology, part of the SyvaStart network for collaborations with academic institutions.
  • Universidad Complutense de Madrid (VISAVET)secondaryStrategic or Co-development PartnerUniversity research center part of the SyvaStart network for collaborations in animal health research.
  • Universidad de Santiago de CompostelasecondaryStrategic or Co-development PartnerGalician university partner in the SyvaStart network for animal health research collaborations.
  • CIBIR (Centro de Investigación Biomédica de La Rioja)secondaryStrategic or Co-development PartnerBiomedical research center in La Rioja, part of the SyvaStart research network.
  • ANSES (Agence nationale de sécurité sanitaire de l'alimentation, de l'environnement et du travail)secondaryStrategic or Co-development PartnerFrench food, environment and occupational health safety agency. Part of SyvaStart network for international research collaborations in animal health.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Laboratorios Syva competitors and assessment

Company assessment

Direct peers

  • Hipra: Spanish-headquartered veterinary pharmaceutical company specializing in vaccines and immunology for livestock and companion animals. Closest geographic and product peer to Syva, both based in Catalonia/León region with comparable species coverage and CMO capabilities for veterinary biologics.
  • Ceva Santé Animale: French-headquartered global animal health company focused on vaccines, pharmaceuticals, and equipment for livestock and companion animals. Comparable to Syva in species breadth and vaccine-led portfolio, though at materially larger scale.
  • Virbac: French-listed global animal health company offering vaccines, parasiticides, and pharmaceuticals for livestock and pets. Similar mid-sized independent positioning, multi-species portfolio, and CMHO/CDMO relevance to Syva, making it a key structural comparator.
  • Vetoquinol: Independent French-listed animal health company with a portfolio of pharmaceuticals and vaccines for livestock and companion animals. Comparable mid-sized European competitor with similar species and therapeutic-area coverage to Syva.
  • Phibro Animal Health: US-listed animal health and nutrition company with significant livestock pharmaceutical and vaccine businesses, including a meaningful nutritional/health products portfolio. Mid-sized independent competitor with overlapping species focus and therapeutic categories.

Broad incumbents

  • Zoetis: World's largest animal health company offering vaccines, anti-infectives, parasiticides, and diagnostics across livestock and companion animals. Competes with Syva in core vaccine and antibiotic categories but at significantly larger scale and broader geographic footprint.
  • Boehringer Ingelheim Animal Health: Global animal health division of Boehringer Ingelheim and a top-three player in livestock vaccines, including strong positions in bovine and porcine biologicals. Directly competes with Syva in livestock vaccines and therapeutics across the EU and global markets.
  • Elanco Animal Health: Large US-listed global animal health company offering livestock vaccines, antibiotics, parasiticides, and companion animal therapeutics. Overlaps with Syva in livestock pharmaceuticals and anti-infectives at a much larger scale.
  • MSD Animal Health (Merck Animal Health): Animal health division of Merck & Co., a global leader in livestock and companion animal vaccines and pharmaceuticals. Competes with Syva in vector-borne disease vaccines (Bluetongue, EHD) and in core livestock anti-infectives, with vastly deeper R&D resources.

Emerging players

  • Indian Immunologicals Limited: India-based veterinary vaccine manufacturer with growing presence in livestock and aquaculture biologics in Asia, Africa, and Latin America. Earlier-stage and geographically focused, but operationally relevant as a low-cost veterinary vaccine producer competing in emerging markets where Syva also distributes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Laboratorios Syva social profiles

Digital presence

Laboratorios Syva compliance and trust

Trust signal

Compliance3 records

Laboratorios Syva financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Laboratorios Syva leadership team

Management profile

Number of profiles

Profiles1 record

Laboratorios Syva subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Laboratorios Syva funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Laboratorios Syva M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Syva

What does Laboratorios Syva do?

Laboratorios Syva is a Spanish veterinary pharmaceutical manufacturer that develops, registers, and commercializes vaccines (immunologics) and antibiotics (betalactams and other anti-infectives) for livestock (bovine, porcine, ovine, caprine, poultry, fish, equine) and companion animals (cats, dogs). The company also offers contract manufacturing services for third parties, leveraging three own manufacturing plants in Spain with capacity of 13.5 million units (675 million vaccine doses) annually.

Is Laboratorios Syva a public or private company?

Laboratorios Syva is a private company. It is classified as unknown and is currently operating.

When was Laboratorios Syva founded?

Laboratorios Syva was founded in 1941. It employs 251 to 500 people.

Where is Laboratorios Syva based?

Laboratorios Syva is headquartered in León, Spain, in the Europe region.

How does Laboratorios Syva make money?

Two revenue lines are on record. Veterinary Pharmaceuticals Sales are the primary driver. The others are contract Manufacturing (CMO).

Who are Laboratorios Syva's main competitors?

Direct peers on record are Hipra, Ceva Santé Animale, Virbac, Vetoquinol and Phibro Animal Health. Broad incumbents are Zoetis, Boehringer Ingelheim Animal Health, Elanco Animal Health and MSD Animal Health (Merck Animal Health). Indian Immunologicals Limited is listed as an emerging player.

Does Laboratorios Syva have an API?

No public API is recorded for Laboratorios Syva.

What industry is Laboratorios Syva in?

Laboratorios Syva's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAKAI, Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO). Its SIC code is 200.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales